vs

Side-by-side financial comparison of Cytosorbents Corp (CTSO) and Spire Global, Inc. (SPIR). Click either name above to swap in a different company.

Spire Global, Inc. is the larger business by last-quarter revenue ($15.8M vs $9.2M, roughly 1.7× Cytosorbents Corp). Cytosorbents Corp runs the higher net margin — -59.5% vs -176.6%, a 117.1% gap on every dollar of revenue. On growth, Cytosorbents Corp posted the faster year-over-year revenue change (0.9% vs -26.9%). Cytosorbents Corp produced more free cash flow last quarter ($-4.9M vs $-16.2M). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -32.6%).

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

Spire Global, Inc. is a space-to-cloud data and analytics company that specializes in the tracking of global data sets powered by a large constellation of nanosatellites, such as the tracking of maritime, aviation and weather patterns.

CTSO vs SPIR — Head-to-Head

Bigger by revenue
SPIR
SPIR
1.7× larger
SPIR
$15.8M
$9.2M
CTSO
Growing faster (revenue YoY)
CTSO
CTSO
+27.8% gap
CTSO
0.9%
-26.9%
SPIR
Higher net margin
CTSO
CTSO
117.1% more per $
CTSO
-59.5%
-176.6%
SPIR
More free cash flow
CTSO
CTSO
$11.2M more FCF
CTSO
$-4.9M
$-16.2M
SPIR
Faster 2-yr revenue CAGR
CTSO
CTSO
Annualised
CTSO
1.3%
-32.6%
SPIR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTSO
CTSO
SPIR
SPIR
Revenue
$9.2M
$15.8M
Net Profit
$-5.5M
$-28.0M
Gross Margin
73.7%
40.2%
Operating Margin
-47.5%
-164.1%
Net Margin
-59.5%
-176.6%
Revenue YoY
0.9%
-26.9%
Net Profit YoY
27.4%
42.7%
EPS (diluted)
$-0.09
$-0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSO
CTSO
SPIR
SPIR
Q4 25
$9.2M
$15.8M
Q3 25
$9.5M
$12.7M
Q2 25
$9.6M
$19.2M
Q1 25
$8.7M
$23.9M
Q4 24
$9.2M
$21.7M
Q3 24
$8.6M
$28.6M
Q2 24
$8.8M
$25.4M
Q1 24
$9.0M
$34.8M
Net Profit
CTSO
CTSO
SPIR
SPIR
Q4 25
$-5.5M
$-28.0M
Q3 25
$-3.2M
$-19.7M
Q2 25
$1.9M
$119.6M
Q1 25
$-1.5M
$-20.7M
Q4 24
$-7.6M
$-48.8M
Q3 24
$-2.8M
$-12.5M
Q2 24
$-4.3M
$-16.6M
Q1 24
$-6.1M
$-25.5M
Gross Margin
CTSO
CTSO
SPIR
SPIR
Q4 25
73.7%
40.2%
Q3 25
70.3%
36.6%
Q2 25
70.9%
48.9%
Q1 25
71.1%
36.8%
Q4 24
68.4%
32.4%
Q3 24
61.0%
44.5%
Q2 24
73.5%
43.0%
Q1 24
76.5%
26.5%
Operating Margin
CTSO
CTSO
SPIR
SPIR
Q4 25
-47.5%
-164.1%
Q3 25
-30.2%
-166.1%
Q2 25
-37.6%
-122.7%
Q1 25
-44.5%
-106.5%
Q4 24
-37.1%
-144.1%
Q3 24
-56.1%
-48.0%
Q2 24
-40.4%
-48.6%
Q1 24
-51.8%
-34.4%
Net Margin
CTSO
CTSO
SPIR
SPIR
Q4 25
-59.5%
-176.6%
Q3 25
-33.4%
-155.3%
Q2 25
20.2%
623.4%
Q1 25
-16.9%
-86.5%
Q4 24
-82.7%
-225.2%
Q3 24
-32.1%
-43.7%
Q2 24
-48.6%
-65.2%
Q1 24
-67.7%
-73.3%
EPS (diluted)
CTSO
CTSO
SPIR
SPIR
Q4 25
$-0.09
$-0.85
Q3 25
$-0.05
$-0.61
Q2 25
$0.03
$3.72
Q1 25
$-0.02
$-0.77
Q4 24
$-0.14
$-1.93
Q3 24
$-0.05
$-0.50
Q2 24
$-0.08
$-0.68
Q1 24
$-0.11
$-1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSO
CTSO
SPIR
SPIR
Cash + ST InvestmentsLiquidity on hand
$6.2M
$81.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.9M
$112.9M
Total Assets
$44.2M
$211.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSO
CTSO
SPIR
SPIR
Q4 25
$6.2M
$81.8M
Q3 25
$7.5M
$96.8M
Q2 25
$10.2M
$117.6M
Q1 25
$11.6M
$35.9M
Q4 24
$3.3M
$19.2M
Q3 24
$5.7M
$36.6M
Q2 24
$8.5M
$45.8M
Q1 24
$8.6M
$63.7M
Total Debt
CTSO
CTSO
SPIR
SPIR
Q4 25
Q3 25
Q2 25
Q1 25
$103.7M
Q4 24
$103.1M
Q3 24
$13.8M
$4.9M
Q2 24
$13.7M
$4.9M
Q1 24
$4.4M
$123.1M
Stockholders' Equity
CTSO
CTSO
SPIR
SPIR
Q4 25
$5.9M
$112.9M
Q3 25
$9.0M
$133.1M
Q2 25
$11.6M
$149.2M
Q1 25
$14.5M
$3.7M
Q4 24
$11.1M
$-11.7M
Q3 24
$13.4M
$30.8M
Q2 24
$17.4M
$40.3M
Q1 24
$19.6M
$52.5M
Total Assets
CTSO
CTSO
SPIR
SPIR
Q4 25
$44.2M
$211.0M
Q3 25
$45.8M
$224.3M
Q2 25
$48.0M
$239.5M
Q1 25
$50.8M
$208.8M
Q4 24
$47.4M
$193.6M
Q3 24
$47.8M
$224.2M
Q2 24
$53.4M
$230.8M
Q1 24
$47.1M
$252.3M
Debt / Equity
CTSO
CTSO
SPIR
SPIR
Q4 25
Q3 25
Q2 25
Q1 25
27.92×
Q4 24
Q3 24
1.03×
0.16×
Q2 24
0.78×
0.12×
Q1 24
0.23×
2.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSO
CTSO
SPIR
SPIR
Operating Cash FlowLast quarter
$-4.8M
$-4.3M
Free Cash FlowOCF − Capex
$-4.9M
$-16.2M
FCF MarginFCF / Revenue
-53.4%
-102.1%
Capex IntensityCapex / Revenue
1.2%
75.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.5M
$-92.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSO
CTSO
SPIR
SPIR
Q4 25
$-4.8M
$-4.3M
Q3 25
$-2.6M
$-12.0M
Q2 25
$-1.5M
$-35.1M
Q1 25
$-3.5M
$-8.4M
Q4 24
$-2.3M
$-19.2M
Q3 24
$-2.5M
$14.0M
Q2 24
$-4.8M
$-4.4M
Q1 24
$-4.8M
$-8.8M
Free Cash Flow
CTSO
CTSO
SPIR
SPIR
Q4 25
$-4.9M
$-16.2M
Q3 25
$-2.6M
$-20.4M
Q2 25
$-1.5M
$-38.7M
Q1 25
$-3.5M
$-17.3M
Q4 24
$-2.4M
$-24.3M
Q3 24
$-2.6M
$5.1M
Q2 24
$-4.8M
$-9.9M
Q1 24
$-4.9M
$-15.9M
FCF Margin
CTSO
CTSO
SPIR
SPIR
Q4 25
-53.4%
-102.1%
Q3 25
-27.3%
-161.3%
Q2 25
-16.1%
-201.7%
Q1 25
-39.7%
-72.6%
Q4 24
-26.3%
-112.2%
Q3 24
-30.4%
17.8%
Q2 24
-54.4%
-39.0%
Q1 24
-54.2%
-45.7%
Capex Intensity
CTSO
CTSO
SPIR
SPIR
Q4 25
1.2%
75.1%
Q3 25
0.2%
66.2%
Q2 25
0.4%
18.8%
Q1 25
0.0%
37.3%
Q4 24
0.8%
23.5%
Q3 24
1.8%
31.2%
Q2 24
0.2%
21.8%
Q1 24
0.5%
20.3%
Cash Conversion
CTSO
CTSO
SPIR
SPIR
Q4 25
Q3 25
Q2 25
-0.78×
-0.29×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

SPIR
SPIR

Segment breakdown not available.

Related Comparisons